# FDA Inspection 992393 - Pharmasyn, Inc. - October 21, 2016

Source: https://www.keypedia.com/records/fda_inspections/pharmasyn-inc/2b02cf5f-3863-4bfa-821d-3f7e55c6e92f
Source feed: FDA_Inspections

> FDA Inspection 992393 for Pharmasyn, Inc. on October 21, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 992393
- Company Name: Pharmasyn, Inc.
- Inspection Date: 2016-10-21
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 716910 - 2011-03-30](https://www.keypedia.com/records/fda_inspections/pharmasyn-inc/f5f0fa84-3d63-40d7-9a56-d5d40dd431a7)

Company: https://www.keypedia.com/companies/pharmasyn-inc/2dce4f42-e186-4816-baaf-b6605a919fd4

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c